These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13171731)

  • 1. [Experimental determination of the prolonged effects of preparations of clupeine zinc insulin and salmine zinc insulin].
    HERBAIN M
    Ann Pharm Fr; 1954 Feb; 12(2):121-5. PubMed ID: 13171731
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractionation of basic proteins and polypeptides; clupeine and salmine.
    SCANES FS; TOZER BT
    Biochem J; 1956 Aug; 63(4):565-76. PubMed ID: 13355851
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth of human carcinomatous elements in media containing clupeine and salmine].
    SIMONELLI L; GUIDOTTI L; MANZOLI FA
    Boll Soc Ital Biol Sper; 1963 Apr; 39():487-9. PubMed ID: 13977516
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and amino acid composition of salmin and clupein.
    BLOCK RJ; BOLLING D
    Proc Soc Exp Biol Med; 1949 Mar; 70(3):494-6. PubMed ID: 18116458
    [No Abstract]   [Full Text] [Related]  

  • 5. Lente insulin, clinical study of a new insulin zinc preparation of prolonged action.
    HOLCOMB B; PAGE OC; STEPHENS JW
    Northwest Med; 1954 Mar; 53(3):239-41. PubMed ID: 13154705
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of zinc in insulin preparations with EDTA].
    Nagasawa K; Shirai J
    Eisei Shikenjo Hokoku; 1970; 88():67-8. PubMed ID: 4993929
    [No Abstract]   [Full Text] [Related]  

  • 7. A [meso-tetrakis(4-sulfonatophenyl)porphyrinato]zinc(ii) complex as an oral therapeutic for the treatment of type 2 diabetic KKA(y) mice.
    Saha TK; Yoshikawa Y; Sakurai H
    ChemMedChem; 2007 Feb; 2(2):218-25. PubMed ID: 17245806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical investigations on new preparations of prolonged action insulin; zinc-insulin preparation for daily injection].
    JERSILD M; HALLAS-MOLLER K; PETERSEN K; SCHLICHTKRULL J
    Sem Med; 1954 Jul; 105(3):110-4. PubMed ID: 13195807
    [No Abstract]   [Full Text] [Related]  

  • 9. Local insulin-zinc injection accelerates skin donor site wound healing.
    Zhang XJ; Wu X; Wolf SE; Hawkins HK; Chinkes DL; Wolfe RR
    J Surg Res; 2007 Sep; 142(1):90-6. PubMed ID: 17597156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polarographical determination of zinc in an injectable suspension of protamine zinc insulin].
    VIGNOLI L; CRISTAU B
    Med Trop (Mars); 1958; 18(3):498-501. PubMed ID: 13564952
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of sub-deficient zinc status on insulin sensitivity after burn injury in rats.
    Claeyssen R; Andriollo-Sanchez M; Arnaud J; Touvard L; Alonso A; Chancerelle Y; Roussel AM; Agay D
    Biol Trace Elem Res; 2009 Feb; 127(2):132-42. PubMed ID: 18800198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible pegylation of insulin facilitates its prolonged action in vivo.
    Shechter Y; Mironchik M; Rubinraut S; Tsubery H; Sasson K; Marcus Y; Fridkin M
    Eur J Pharm Biopharm; 2008 Sep; 70(1):19-28. PubMed ID: 18495444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypoglycemic action of insulin-zinc-globin product].
    SPASOWICZ T
    Pol Tyg Lek (Wars); 1954 Jan; 9(4):121-2. PubMed ID: 13166700
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of prolonged action of zinc iontophoresis on insulin effect].
    KASATKINA LV
    Patol Fiziol Eksp Ter; 1957; 1(4):32-8. PubMed ID: 13494048
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.
    Kwon JH; Lee BH; Lee JJ; Kim CW
    Eur J Pharm Sci; 2004 Jun; 22(2-3):107-16. PubMed ID: 15158896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of the buccal permeability of insulin].
    Starokadoms'kyĭ PL
    Fiziol Zh (1994); 2006; 52(4):90-7. PubMed ID: 16958222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo.
    Zhou H; Zhang T; Harmon JS; Bryan J; Robertson RP
    Diabetes; 2007 Apr; 56(4):1107-12. PubMed ID: 17317764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants.
    Haase H; Maret W
    Biometals; 2005 Aug; 18(4):333-8. PubMed ID: 16158225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.